Hepatitis C virus antibody status, sociodemographic characteristics, and risk behaviour among injecting drug users in Croatia

Central European Journal of Public Health

Volumn 19, Issue 1, 2011, Pages 26-29

  Čavlek, Tatjana Vilibić ^a,b   Marić, Jelena ^a   Katičić, Ljiljana ^a   Kolarić, Branko ^c,d  

^a CROATIAN NATIONAL INSTITUTE OF PUBLIC HEALTH   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c Zagreb County Institute of Public Health   (Croatia)

^d UNIVERSITY OF RIJEKA   (Croatia)

Author keywords

Hepatitis C; IDU; Risk factors; Seroprevalence

Indexed keywords

EID: 79954498230     PISSN: 12107778     EISSN: None     Source Type: Journal    
DOI: 10.21101/cejph.a3602     Document Type: Article

References (25)

1. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat. 1999 Jan;6(1):35-47.
2. Thorpe LE, Ouellet LJ, Hershow R, Bailey SL, Williams IT, Williamson J, et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol. 2002 Apr 1;155(7):645-53.
3. Merkinaite S, Lazarus JV, Gore C. Addressing HCV infection in Europe: reported, estimated and undiagnosed cases. Cent Eur J Public Health. 2008 Sep;16(3):106-10.
4. Kyrychenko PD. Seroprevalence of HIV and HCV markers among injection drug users seeking medical care. In: 15th International conference on AIDS; 2004 Jul 11-16; Bangkok, Thailand. Bangkok: 2004; abstract no. MoPeC3526.
5. Vassilev ZP, Hagan H, Lyubenova A, Tomov N, Vasilev G, Krasteva D, et al. Needle exchange use, sexual risk behaviour, and the prevalence of HIV, hepatitis B virus, and hepatitis C virus infections among Bulgarian injection drug users. Int J STD AIDS. 2006 Sep;17(9):621-6.
6. Smyth BP, Barry J, Keenan E. Irish injecting drug users and hepatitis C: the importance of the social context of injecting. Int J Epidemiol. 2005 Feb;34(1):166-72.
7. Hickman M, Hope V, Brady T, Madden P, Jones S, Honor S, et al. Hepatitis C virus (HCV) prevalence, and injecting risk behaviour in multiple sites in England in 2004. J Viral Hepat. 2007 Sep;14(9):645-52.
8. Vicente J, Wiessing L; EMCDDA, national focal points and expert networks. European Monitoring Centre for Drugs and Drug Addiction annual report 2007: positive assessment of HIV in IDUs though hepatitis C still very high. Euro Surveill. 2007 Nov 22;12(11):E071122.6.
9. Jadoul M, Poignet JL, Geddes C, Locatelli F, Medin C, Krajewska M, et al; HCV Collaborative Group. The changing epidemiology of hepatitis C virus (HCV) infection in haemodialysis: European multicentre study. Nephrol Dial Transplant. 2004 Apr;19(4):904-9.
10. Olut AI, Ozsakarya F, Dilek M. Seroprevalence of hepatitis C virus infection and evaluation of serum aminotransferase levels among haemodialysis patients in Izmir, Turkey. J Int Med Res. 2005 Nov-Dec;33(6):641-6.
11. World Hepatitis Awareness Day, 2007. HCV infection in Europe. Vilnius: Eurasian Harm Reduction Network; 2007.
12. Wiessing L, Guarita B, Giraudon I, Brummer-Korvenkontio H, Salminen M, Cowan SA. European monitoring of notifications of hepatitis C virus infection in the general population and among injecting drug users (IDUs)-the need to improve quality and comparability. Euro Surveill. 2008 May 22;13(21):pii 18884.
13. Xia X, Luo J, Bai J, Yu R. Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis. Public Health. 2008 Oct;122(10):990-1003.
14. Thomas DL, Zenilman JM, Alter HJ, Shih JW, Galai N, Carella AV, et al. Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore: an analysis of 309 sex partnerships. J Infect Dis. 1995 Apr;171(4):768-75.
15. Wejstål R. Sexual transmission of hepatitis C virus. J Hepatol. 1999;31 Suppl 1:92-5.
16. Cavlek TV, Margan IG, Lepej SZ, Kolaric B, Vince A. Seroprevalence, risk factors, and hepatitis C virus genotypes in groups with high-risk sexual behavior in Croatia. J Med Virol. 2009 Aug;81(8):1348-53.
17. Gjenero-Margan I, Kolarić B. Epidemiology of HIV infection and AIDS in Croatia-an overview. Coll Antropol. 2006 Dec;30 Suppl 2:11-6.
18. Kolarić B, Štajduhar D, Gajnik D, Rukavina T, Wiessing L. Seroprevalence of blood-borne infections and population sizes estimates in a population of injecting drug users in Croatia. Cent Eur J Public Health. 2010 Jun;18(2):104-9.
19. Jittiwutikarn J, Thongsawat S, Suriyanon V, Maneekarn N, Celentano D, Razak MH, et al. Hepatitis C infection among drug users in northern Thailand. Am J Trop Med Hyg. 2006 Jun;74(6):1111-6.
20. Garten RJ, Lai S, Zhang J, Liu W, Chen J, Vlahov D, et al. Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. Int J Epidemiol. 2004 Feb;33(1):182-8.
21. Hershow RC, Kalish LA, Sha B, Till M, Cohen M. Hepatitis C virus infection in Chicago women with or at risk for HIV infection: evidence for sexual transmission. Sex Transm Dis. 1998 Nov;25(10):527-32.
22. Barros H, Ramos E, Lucas R. A survey of HIV and HCV among female prison inmates in Portugal. Cent Eur J Public Health. 2008 Sep;16(3):116-20.
23. Medić A, Dželalija B, Sonicki Z, Zekanović D. Characteristics of hepatitis C infection in injecting drug users in Zadar County, Croatia. Coll Antropol. 2008 Sep;32(3):697-702.
24. Wong T, Lee SS. Hepatitis C: a review for primary care physicians. CMAJ. 2006 Feb 28;174(5):649-59.
25. Hahn JA, Page-Shafer K, Ford J, Paciorek A, Lum PJ. Traveling young injection drug users at high risk for acquisition and transmission of viral infections. Drug Alcohol Depend. 2008 Jan 11;93(1-2):43-50.